-Catherine Rice-Evans Researcher Activity Profile

Research Author Detailed Information 

Catherine Rice-Evans Publication Rate By Year

Catherine Rice-Evans has published 1 paper(s) in 2006, 4 paper(s) in 2007, for a total of 5 research publications in total.

Catherine C Rice-Evans Author Information

LAST NAME: rice-evans

FIRST NAME: Catherine

INITIALS: c

AFFILIATION:

Papers

Catherine Rice-Evans's Publication Record

1. The intracellular genistein metabolite 5,7,3',4'-tetrahydroxyisoflavone mediates G2-M cell cycle arrest in cancer cells via modulation of the p38 signaling pathway. Year Published: 2006
Department of Molecular Pharmacology & Toxicology, School of Pharmacy, University of Southern California, Los Angeles, CA 90089, USA.
2. Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. Year Published: 2007
Molecular Nutrition Group, School of Chemistry, Food and Pharmacy, University of Reading, Reading, UK.
3. Inhibition of cellular proliferation by the genistein metabolite 5,7,3',4'-tetrahydroxyisoflavone is mediated by DNA damage and activation of the ATR signalling pathway. Year Published: 2007
Molecular Nutrition Group, School of Chemistry, Food and Pharmacy, University of Reading, Whiteknights, Reading RG2 6AP, UK.
4. Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. Year Published: 2007
Molecular Nutrition Group, School of Chemistry, Food and Pharmacy, University of Reading, Reading, UK.
5. Inhibition of cellular proliferation by the genistein metabolite 5,7,3',4'-tetrahydroxyisoflavone is mediated by DNA damage and activation of the ATR signalling pathway. Year Published: 2007
Molecular Nutrition Group, School of Chemistry, Food and Pharmacy, University of Reading, Whiteknights, Reading RG2 6AP, UK.